Ali Ajam

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 224 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

Cathie Spino, Richard McLain, Sindhu R. Johnson et al. · The Lancet Rheumatology · 2020 · 46 citations · Full text

Medicine, Dermatology, Pharmacotherapy +8

Sex and age difference in risk factor distribution, trend, and long-term outcome of patients undergoing isolated coronary artery bypass graft surgery

Babak Sattartabar, Ali Ajam, Mina Pashang et al. · BMC Cardiovascular Disorders · 2021 · 25 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial

Ramin Hamidi Farahani, Ali Ajam, Alireza Ranjbar Naeini · BMC Infectious Diseases · 2023 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG

Aida Fallahzadeh, Ali Sheikhy, Ali Ajam et al. · Journal of Cardiothoracic Surgery · 2021 · 17 citations · Full text

Medicine, Cardiology, Surgery +16